(Q33881726)

29 July 2017

1 reference

title

New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us? (English)

1 reference

29 July 2017

0 references

0 references

1

Anders M Fjell

1 reference

29 July 2017

Kristine Beate Walhovd

series ordinal

2

object named as

Kristine B Walhovd

1 reference

29 July 2017

language of work or name

1 reference

25 April 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

17

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

592-605

1 reference

Increasing CSF phospho-tau levels during cognitive decline and progression to dementia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Probing the biology of Alzheimer's disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

The cortical signature of prodromal AD: regional thinning predicts mild AD dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

CSF markers for incipient Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Forecasting the global burden of Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

The cognitive neuroscience of remembering

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

The precuneus: a review of its functional anatomy and behavioural correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Early marker for Alzheimer's disease: the atrophic hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Structural MRI biomarkers for preclinical and mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

One-year brain atrophy evident in healthy aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

PET imaging of amyloid deposition in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Spatial representation in the entorhinal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

A century of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Subregional neuroanatomical change as a biomarker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Determinants of costs of care for patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Boosting power for clinical trials using classifiers based on multiple biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Amyloid beta: the alternate hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Regional rates of neocortical atrophy from normal aging to early Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Alzheimer's disease sends the wrong signals--a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Reassessing the amyloid cascade hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

The value of incomplete mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

White matter pathology isolates the hippocampal formation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Loss of recent memory after bilateral hippocampal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Tau pathophysiology in neurodegeneration: a tangled issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

What does the retrosplenial cortex do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Differentiating maturational and aging-related changes of the cerebral cortex by use of thickness and signal intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

Amyloid beta and APP as biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410392586

21 January 2018

Identifiers

DOI

10.1177/1073858410392586

1 reference

29 July 2017

1 reference